How much does a box of 0.01% atropine sulfate eye drops cost? Does it vary by region or pharmacy?

The original drug of 0.01% atropine sulfate eye drops (EIKANCE) has not yet been launched in China, so the specific domestic price is not yet clear. This drug is not included in medical insurance, which means that domestic patients may not be able to purchase this drug through medical insurance reimbursement. Despite this, atropine sulfate eye drops are available as original drugs overseas. The common specifications are 0.01% 0.3ml 30 tubes, and each box is priced at more than 600 yuan. However, this price may vary according to different pharmacies and regions, especially taking into account factors such as international logistics, taxes and fees.

In addition, in overseas markets, many countries and regions have launched generic versions of atropine sulfate eye drops, and the prices are relatively low. For example, the specifications of generic drugs produced in India are 0.01% w/v*5ml, and each drug is usually sold for tens of RMB. These generic drugs are basically the same as the brand-name drugs in terms of ingredients, so they may be an affordable option for patients who need to use atropine sulfate eye drops.

The price difference is not only reflected between original drugs and generic drugs, but may also be affected by regional differences. Drug market pricing strategies, production costs, import tariffs and other factors in different countries and regions will lead to different selling prices of the same drug. Especially for drugs that need to be purchased across borders, patients may need to bear higher shipping costs and taxes, which will further affect the final price of the drug.

In general, the price of 0.01%Atropine Sulfate Eye Drops may fluctuate in different regions and pharmacies, especially if it is not yet available in the country. When purchasing, in addition to paying attention to the source and quality of drugs, patients also need to consider price and transportation costs. Generic drugs offer a more economical option, but the quality and efficacy of the drug need to be ensured when choosing to ensure the safety of the treatment.

Reference materials:https://www.medsafe.govt.nz/profs/datasheet/e/EikanceEyeDrops.pdf